The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.
A letter dated May 24 from Qilu's deputy general manager notified health-care professionals of the approval.
Qilu, which is headquartered in the city of Jinan in Shandong province, says it is one of the 10 largest drug manufacturers in China.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Ex-NYPD Sgt., others accused of harassing and intimidating Chinese dissidents in USA retired NYPD sergeant and two Chinese nationals are charged with working with the Chinese government to harass and intimidate Chinese dissidents living in the U.S.
Weiterlesen »
Shortage of lifesaving chemo drugs adds to cancer patients' fearsThe FDA says more than a dozen cancer drugs are in short supply, including Carboplatin.
Weiterlesen »
Ozempic Craze Has Spawned a Sketchy Black Market, FDA WarnsThe FDA has received adverse event reports from people using compounded semaglutide, which might not contain the same version of the popular obesity drug.
Weiterlesen »
Pfizer gets FDA approval for RSV vaccine Abrysvo in older adultsPfizer Inc. said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug...
Weiterlesen »
FDA approves Pfizer RSV vaccine for older adultsThe approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a similar shot made by GSK.
Weiterlesen »
FDA approves Pfizer’s RSV vaccine for older adults | CNNThe US Food and Drug Administration on Wednesday approved Pfizer’s RSV vaccine for older adults, the second such shot approved for the common virus.
Weiterlesen »